DOCSLIB.ORG

Construction of a Knockout Mouse Model For

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Construction of a Knockout Mouse Model For Construction of a knockout mouse model for combined methylmalonic aciduria and homocystinuria, cblC type (Mmachc) By Junhui Liu Department of Human Genetics McGill University, Montreal, Canada A thesis submitted to McGill University in partial fulfilment of the requirements of the degree of Master © Junhui Liu, December 2009 1 TABLE OF CONTENTS ABSTRACT ..................................................................................................................... 5 RÉSUMÉ ......................................................................................................................... 6 ACKNOWLEDGEMENTS ............................................................................................ 7 LIST OF FIGURES ........................................................................................................ 8 LIST OF TABLES .......................................................................................................... 9 ABBREVIATIONS ....................................................................................................... 10 CHAPTER 1. Introduction ........................................................................................... 12 Chapter 1.1 Cobalamin ............................................................................................. 12 1.1.1 Vitamin B12 .................................................................................................. 12 1.1.2 Structure of cobalamin ................................................................................. 12 1.1.3 Distribution of cobalamins among life forms ............................................. 16 1.1.4 Cobalamin uptake and transport in mammals ........................................... 16 1.1.5 Intracellular cobalamin metabolism ........................................................... 18 1.1.6 Molecular and functional aspects of cobalamin metabolism ..................... 20 cblA, cblB and mut ............................................................................................. 21 cblA: ............................................................................................................... 22 cblB: ............................................................................................................... 23 mut: ................................................................................................................ 23 cblC, cblD and cblF ............................................................................................ 24 cblC: This will be discussed in details in Chapter 1.3 later. ....................... 24 cblD: ............................................................................................................... 24 2 cblF: ................................................................................................................ 24 cblE, cblG and cblD variant 1 ............................................................................ 25 cblE: ............................................................................................................... 26 cblG: ............................................................................................................... 26 Methylenetetrahydrofolate reductase (MTHFR) deficiency ........................... 27 1.1.7 Cobalamin and birth defects ........................................................................ 28 Chapter 1.2 Knockout mouse models for genes in cobalamin metabolism and transport pathway ..................................................................................................... 29 1.2.1 Methylenetetrahydrofolate reductase (Mthfr) knockout mouse model ..... 29 1.2.2 Methionine synthase (Mtr) knockout mouse model .................................... 30 1.2.3 Methionine synthase reductase (Mtrr) knockout mouse model ................. 30 1.2.4 Mut knockout mouse model ......................................................................... 31 1.2.5 Cubn knockout mouse model ....................................................................... 31 1.2.6 Amn mouse model ......................................................................................... 31 Chapter 1.3 MMACHC.............................................................................................. 32 RATIONALE AND OBJECTIVES OF RESEARCH ................................................ 38 CHAPTER 2. Materials and Methods ......................................................................... 39 Chapter 2.1 Generation of knockout mouse model: ............................................... 39 2.1.1 Gene trap information .................................................................................. 39 2.1.2 Evaluation of the gene trap construct ......................................................... 40 2.1.3 Generation of chimeric mice ........................................................................ 42 2.1.4 Generation of F1 mice and molecular characterization of the MMACHC knockout mice ........................................................................................................ 42 3 2.1.5 Embryo Studies ............................................................................................. 42 Chapter 2.2 Molecular Characterization ................................................................. 43 2.2.1 DNA extraction ............................................................................................. 43 2.2.2 RNA extraction ............................................................................................. 43 2.2.3 Sequencing analysis ...................................................................................... 44 Chapter 2.3 Biochemical analysis ............................................................................. 45 2.3.1 Measurement of metabolites in the blood and urine .................................. 45 2.3.2 Fibroblast studies ......................................................................................... 45 2.3.2a Cell culture .............................................................................................. 45 2.3.2b Cell lines .................................................................................................. 45 2.3.2c Propionate incorporation studies ........................................................... 46 2.3.2d Methyltetrahydrofolate incorporation studies ..................................... 47 CHAPTER 3. Results .................................................................................................... 48 Chapter 3.1 Molecular and biochemical characterization of adult mice ............... 48 Chapter 3.2 Molecular characterization of mouse embryos .................................. 55 Chapter 3.3 Embryo morphology ............................................................................ 56 Chapter 3.4 MCM and MS function of mouse fibroblasts ..................................... 60 CHAPTER 4. Discussion .............................................................................................. 65 SUMMARY AND CONCLUSION .............................................................................. 73 CLAIMS OF ORIGINALITY ...................................................................................... 74 BIBLIOGRAPHY ......................................................................................................... 75 APPENDIX A: PUBLICATIONS AND PRESENTATIONS .................................... 85 APPENDIX B: ETHICS AND CERTIFICATES ....................................................... 90 4 ABSTRACT The MMACHC gene is responsible for cblC, the most common inborn error of cobalamin metabolism in man. We created a knockout mouse model for its ortholog, Mmachc. Embryonic stem cells from 129 strain mice heterozygous for Mmachc containing a gene trap in intron 1 were injected into blastocysts from c57B6 mice to generate chimeras. Crossing chimeric males to c57B6 females generated heterozygous F1 mice. Geonotyping of F2 mice showed 36 wild type, 71 heterozygous and 3 homozygous. The three homozygous mutant F2 mice had a normal phenotype possibly due to alternative splicing causing expression of wild type Mmachc. Genotyping of embryos showed absence of homozygous mutants at e17.5, suggesting they died earlier. We observed phenotypes including open neural folds, amnionless-like, holoprosencephaly and abnormal limbs and face in individual homozygous mutant embryos. This work enables us to further clarify functions of Mmachc and the role of it in birth defects. 5 RÉSUMÉ Chez l’homme, le gène MMACHC est responsable de la maladie cblC qui est l’erreur innée la plus commune de sentier de métabolique de la cobalamine. Nous avons créé un modèle de souris knockout pour son orthologue--Mmachc. Des cellules souches embryonnaires de type 129 heterozygotes pour un gène piégé dans l’intron 1 de Mmachc ont été injectées dans des blastocystes de type c57B6 afin de produire des chimères. Le croisement de mâles chimériques et de femelles de type c57B6 a produit des mutants hétérozygotes F1. Le génotypage a démontré 36 souris de type sauvage, 71 hétérozygotes et 3 homozygotes. Le génotypage a démontré l'absence d'embryons homozygotes mutants à e17.5, suggérant que les embryons homozygotes mutants sont morts avant e17.5. Nous avons observé des dysmorphologies telles que des plis neuronaux ouverts, un phenotype similaire à ‘amnionless’, de l’holoprosencephaly et des membres et visages anormaux dans les embryons homozygotes mutants. Les trois souris homozygotes
Load more

Recommended publications
  • Supplement 1 Overview of Dystonia Genes
    Supplement 1 Overview of genes that may cause dystonia in children and adolescents Gene (OMIM) Disease name/phenotype Mode of inheritance 1: (Formerly called) Primary dystonias (DYTs): TOR1A (605204) DYT1: Early-onset generalized AD primary torsion dystonia (PTD) TUBB4A (602662) DYT4: Whispering dystonia AD GCH1 (600225) DYT5: GTP-cyclohydrolase 1 AD deficiency THAP1 (609520) DYT6: Adolescent onset torsion AD dystonia, mixed type PNKD/MR1 (609023) DYT8: Paroxysmal non- AD kinesigenic dyskinesia SLC2A1 (138140) DYT9/18: Paroxysmal choreoathetosis with episodic AD ataxia and spasticity/GLUT1 deficiency syndrome-1 PRRT2 (614386) DYT10: Paroxysmal kinesigenic AD dyskinesia SGCE (604149) DYT11: Myoclonus-dystonia AD ATP1A3 (182350) DYT12: Rapid-onset dystonia AD parkinsonism PRKRA (603424) DYT16: Young-onset dystonia AR parkinsonism ANO3 (610110) DYT24: Primary focal dystonia AD GNAL (139312) DYT25: Primary torsion dystonia AD 2: Inborn errors of metabolism: GCDH (608801) Glutaric aciduria type 1 AR PCCA (232000) Propionic aciduria AR PCCB (232050) Propionic aciduria AR MUT (609058) Methylmalonic aciduria AR MMAA (607481) Cobalamin A deficiency AR MMAB (607568) Cobalamin B deficiency AR MMACHC (609831) Cobalamin C deficiency AR C2orf25 (611935) Cobalamin D deficiency AR MTRR (602568) Cobalamin E deficiency AR LMBRD1 (612625) Cobalamin F deficiency AR MTR (156570) Cobalamin G deficiency AR CBS (613381) Homocysteinuria AR PCBD (126090) Hyperphelaninemia variant D AR TH (191290) Tyrosine hydroxylase deficiency AR SPR (182125) Sepiaterine reductase
    [Show full text]
  • What Are Knockout Mice?
    Lecture 37 Knockout mice Lecture 29 Cloning and Expression vectors Lecture 30 Eukaryotic Protein Expression Systems –I Lecture 31 Eukaryotic Protein Expression Systems –II Lecture 32 Eukaryotic Protein Expression Systems –III Lecture 33 Human Gene Therapy Lecture 34 DNA Vaccines Lecture 35 Transgenic Animals Lecture 36 Transgenic Plants Lecture 37 Knockout Mice What are knockout mice? A knockout mouse is a mouse in which a specific gene has been inactivated or “knocked out” by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity often causes changes in a mouse's phenotype and thus provides valuable information on the function of the gene. Researchers who developed the technology for the creation of knockout mice won Nobel Prize in the year 2007 The Nobel Prize in Physiology or Medicine 2007 was awarded jointly to Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies "for their discoveries of principles for introducing specific gene modifications in mice by the use of embryonic stem cells". Mario R. Capecchi Sir Martin J. Evans Oliver Smithies The ability to delete or mutate any gene of interest in mice has transformed the landscape of mammalian biology research. Cultivation of embryonic stem (ES) cells – Martin Evans • Gene targeting – Oliver Smithies • Gene knockout – Mario Capecchi Gene correction by Oliver Smithies Targeted correction of a mutant HPRT gene in mouse ES cells. Nature 330:576-8, 1987 This modification of a chosen gene in pluripotent ES cells demonstrates the feasibility of this route to manipulating mammalian genomes in predetermined ways. -------------------------------------------------------------------------------------- Nature. 1985 Sep 19-25;317(6034):230-4.
    [Show full text]
  • The Human Genome Project Focus of the Human Genome Project
    TOOLS OF GENETIC RESEARCH THE HUMAN GENOME PROJECT FOCUS OF THE HUMAN GENOME PROJECT The primary work of the Human Genome Project has been to Francis S. Collins, M.D., Ph.D.; produce three main research tools that will allow investigators to and Leslie Fink identify genes involved in normal biology as well as in both rare and common diseases. These tools are known as positional cloning The Human Genome Project is an ambitious research effort aimed at deciphering the chemical makeup of the entire human (Collins 1992). These advanced techniques enable researchers to ge ne tic cod e (i.e. , the g enome). The primary wor k of the search for disease­linked genes directly in the genome without first having to identify the gene’s protein product or function. (See p ro j e c t i s t o d ev e lop t h r e e r e s e a r c h tool s t h a t w i ll a ll o w the article by Goate, pp. 217–220.) Since 1986, when researchers scientists to identify genes involved in both rare and common 2 diseases. Another project priority is to examine the ethical, first found the gene for chronic granulomatous disease through legal, and social implications of new genetic technologies and positional cloning, this technique has led to the isolation of consid­ to educate the public about these issues. Although it has been erably more than 40 disease­linked genes and will allow the identi­ in existence for less than 6 years, the Human Genome Project fication of many more genes in the future (table 1).
    [Show full text]
  • Abstracts from the 9Th Biennial Scientific Meeting of The
    International Journal of Pediatric Endocrinology 2017, 2017(Suppl 1):15 DOI 10.1186/s13633-017-0054-x MEETING ABSTRACTS Open Access Abstracts from the 9th Biennial Scientific Meeting of the Asia Pacific Paediatric Endocrine Society (APPES) and the 50th Annual Meeting of the Japanese Society for Pediatric Endocrinology (JSPE) Tokyo, Japan. 17-20 November 2016 Published: 28 Dec 2017 PS1 Heritable forms of primary bone fragility in children typically lead to Fat fate and disease - from science to global policy a clinical diagnosis of either osteogenesis imperfecta (OI) or juvenile Peter Gluckman osteoporosis (JO). OI is usually caused by dominant mutations affect- Office of Chief Science Advsor to the Prime Minister ing one of the two genes that code for two collagen type I, but a re- International Journal of Pediatric Endocrinology 2017, 2017(Suppl 1):PS1 cessive form of OI is present in 5-10% of individuals with a clinical diagnosis of OI. Most of the involved genes code for proteins that Attempts to deal with the obesity epidemic based solely on adult be- play a role in the processing of collagen type I protein (BMP1, havioural change have been rather disappointing. Indeed the evidence CREB3L1, CRTAP, LEPRE1, P4HB, PPIB, FKBP10, PLOD2, SERPINF1, that biological, developmental and contextual factors are operating SERPINH1, SEC24D, SPARC, from the earliest stages in development and indeed across generations TMEM38B), or interfere with osteoblast function (SP7, WNT1). Specific is compelling. The marked individual differences in the sensitivity to the phenotypes are caused by mutations in SERPINF1 (recessive OI type obesogenic environment need to be understood at both the individual VI), P4HB (Cole-Carpenter syndrome) and SEC24D (‘Cole-Carpenter and population level.
    [Show full text]
  • Generation of Mouse Conditional Knockout Alleles in One Step Using the I-GONAD Method
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Method Generation of mouse conditional knockout alleles in one step using the i-GONAD method Renjie Shang,1,2 Haifeng Zhang,1 and Pengpeng Bi1,2 1Center for Molecular Medicine, University of Georgia, Athens, Georgia 30602, USA; 2Department of Genetics, University of Georgia, Athens, Georgia 30602, USA The Cre/loxP system is a powerful tool for gene function study in vivo. Regulated expression of Cre recombinase mediates precise deletion of genetic elements in a spatially– and temporally–controlled manner. Despite the robustness of this system, it requires a great amount of effort to create a conditional knockout model for each individual gene of interest where two loxP sites must be simultaneously inserted in cis. The current undertaking involves labor-intensive embryonic stem (ES) cell– based gene targeting and tedious micromanipulations of mouse embryos. The complexity of this workflow poses formida- ble technical challenges, thus limiting wider applications of conditional genetics. Here, we report an alternative approach to generate mouse loxP alleles by integrating a unique design of CRISPR donor with the new oviduct electroporation technique i-GONAD. Showing the potential and simplicity of this method, we created floxed alleles for five genes in one attempt with relatively low costs and a minimal equipment setup. In addition to the conditional alleles, constitutive knockout alleles were also obtained as byproducts of these experiments. Therefore, the wider applications of i-GONAD may promote gene func- tion studies using novel murine models. [Supplemental material is available for this article.] Our understanding of the genetic mechanisms of human diseases strains are readily available, generation of the loxP-flanked (floxed) has been largely expanded by loss-of-function studies using engi- alleles is challenging and labor-intensive due to the lack of an effi- neered mouse models.
    [Show full text]
  • Anti-MMAB Antibody (ARG55862)
    Product datasheet [email protected] ARG55862 Package: 100 μl anti-MMAB antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes MMAB Tested Reactivity Hu Predict Reactivity Ms Tested Application WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name MMAB Antigen Species Human Immunogen KLH-conjugated synthetic peptide corresponding to aa. 50-81 (Center) of Human MMAB. Conjugation Un-conjugated Alternate Names ATR; cob; cblB; CFAP23; Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial; EC 2.5.1.17; Cob(I)alamin adenosyltransferase; Methylmalonic aciduria type B protein Application Instructions Application table Application Dilution WB 1:1000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control HepG2 Calculated Mw 27 kDa Properties Form Liquid Purification Purification with Protein A and immunogen peptide. Buffer PBS and 0.09% (W/V) Sodium azide Preservative 0.09% (W/V) Sodium azide Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Database links GeneID: 326625 Human Swiss-port # Q96EY8 Human Gene Symbol MMAB Gene Full Name methylmalonic aciduria (cobalamin deficiency) cblB type Background This gene encodes a protein that catalyzes the final step in the conversion of vitamin B(12) into adenosylcobalamin (AdoCbl), a vitamin B12-containing coenzyme for methylmalonyl-CoA mutase.
    [Show full text]
  • Oral Presentations
    Journal of Inherited Metabolic Disease (2018) 41 (Suppl 1):S37–S219 https://doi.org/10.1007/s10545-018-0233-9 ABSTRACTS Oral Presentations PARALLEL SESSION 1A: Clycosylation and cardohydrate disorders O-002 Link between glycemia and hyperlipidemia in Glycogen Storage O-001 Disease type Ia Hoogerland J A1, Hijmans B S1, Peeks F1, Kooijman S3, 4, Bos T2, Fertility in classical galactosaemia, N-glycan, hormonal and inflam- Bleeker A1, Van Dijk T H2, Wolters H1, Havinga R1,PronkACM3, 4, matory gene expression interactions Rensen P C N3, 4,MithieuxG5, 6, Rajas F5, 6, Kuipers F1, 2,DerksTGJ1, Reijngoud D1,OosterveerMH1 Colhoun H O1,Rubio-GozalboME2,BoschAM3, Knerr I4,DawsonC5, Brady J J6,GalliganM8,StepienKM9, O'Flaherty R O7,MossC10, 1Dep Pediatrics, CLDM, Univ of Groningen, Groningen, Barker P11, Fitzgibbon M C6, Doran P8,TreacyEP1, 4, 9 Netherlands, 2Lab Med, CLDM, Univ of Groningen, Groningen, Netherlands, 3Dep of Med, Div of Endocrinology, LUMC, Leiden, 1Dept Paediatrics, Trinity College Dublin, Dublin, Ireland, 2Dept Paeds and Netherlands, 4Einthoven Lab Exp Vasc Med, LUMC, Leiden, Clin Genetics, UMC, Maastricht, Netherlands, 3Dept Paediatrics, AMC, Netherlands, 5Institut Nat Sante et Recherche Med, Lyon, Amsterdam, Netherlands, 4NCIMD, TSCUH, Dublin, Ireland, 5Dept France, 6Univ Lyon 1, Villeurbanne, France Endocrinology, NHS Foundation Trust, Birmingham, United Kingdom, 6Dept Clin Biochem, MMUH, Dublin, Ireland, 7NIBRT Glycoscience, Background: Glycogen Storage Disease type Ia (GSD Ia) is an NIBRT, Dublin, Ireland, 8UCDCRC,UCD,Dublin,Ireland,9NCIMD, inborn error of glucose metabolism characterized by fasting hypo- MMUH, Dublin, Ireland, 10Conway Institute, UCD, Dublin, Ireland, glycemia, hyperlipidemia and fatty liver disease. We have previ- 11CBAL, NHS Foundation, Cambridge, United Kingdom ously reported considerable heterogeneity in circulating triglycer- ide levels between individual GSD Ia patients, a phenomenon that Background: Classical Galactosaemia (CG) is caused by deficiency of is poorly understood.
    [Show full text]
  • Case Report Methylmalonic Acidemia with Novel MUT Gene Mutations
    Case Report Methylmalonic Acidemia with Novel MUT Gene Mutations Commented [A 1]: Important: 1.As per the journal, units of measurement should be Inusha Panigrahi, Savita Bhunwal, Harish Varma, and Simranjeet Singh presented simply and concisely using System International (SI) units; please ensure that units are Department of Pediatrics, Advanced Pediatric Centre, PGIMER, Chandigarh, India presented using the SI system at all instances. 2.References for some previously published data is Correspondence: Inusha Panigrahi; [email protected] missing. Please ensure that references are provided Methylmalonic acidemia (MMA) is a rare inherited metabolic disorder caused by deficiency wherever required. of the enzyme methylmalonyl-CoA mutase. The disease is presented in early infancy by 3.Informed consent from the patient is required and lethargy, vomiting, failure to thrive, encephalopathy and is deadly if left untreated. A 5-years should be mentioned in the manuscript. old boy presented with recurrent episodes of fever, feeding problems, lethargy, from the age of For more information, please refer to the guidelines at 11 months, and poor weight gain. He was admitted and evaluated for metabolic causes and https://www.hindawi.com/journals/crig/guidelines/. diagnosed as methylmalonic acidemia (MMA). He was treated with vit B12 and carnitine Commented [A 2]: As per the journal’s guidelines, supplements and has been on follow-up for the last 3 years. Mutation analysis by next please provide email addresses of all the authors. generation sequencing (NGS), supplemented with Sanger sequencing, revealed two novel Formatted: Right: 0 cm, Space Before: 0 pt, Line variants in the MUT gene responsible for MMA in exon 5 and exon 3.
    [Show full text]
  • Generation of Knockout Mouse Models of Cyclin-Dependent Kinase Inhibitors by Engineered Nuclease-Mediated Genome Editing
    ISSN 1738-6055 (Print) ISSN 2233-7660 (Online) Lab Anim Res 2018: 34(4), 264-269 https://doi.org/10.5625/lar.2018.34.4.264 Generation of knockout mouse models of cyclin-dependent kinase inhibitors by engineered nuclease-mediated genome editing Bo Min Park, Jae-il Roh*, Jaehoon Lee*, Han-Woong Lee* Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul, Korea Cell cycle dysfunction can cause severe diseases, including neurodegenerative disease and cancer. Mutations in cyclin-dependent kinase inhibitors controlling the G1 phase of the cell cycle are prevalent in various cancers. Mice lacking the tumor suppressors p16Ink4a (Cdkn2a, cyclin-dependent kinase inhibitor 2a), p19Arf (an alternative reading frame product of Cdkn2a,), and p27Kip1 (Cdkn1b, cyclin-dependent kinase inhibitor 1b) result in malignant progression of epithelial cancers, sarcomas, and melanomas, respectively. Here, we generated knockout mouse models for each of these three cyclin-dependent kinase inhibitors using engineered nucleases. The p16Ink4a and p19Arf knockout mice were generated via transcription activator-like effector nucleases (TALENs), and p27Kip1 knockout mice via clustered regularly interspaced short palindromic repeats/CRISPR-associated nuclease 9 (CRISPR/Cas9). These gene editing technologies were targeted to the first exon of each gene, to induce frameshifts producing premature termination codons. Unlike preexisting embryonic stem cell-based knockout mice, our mouse models are free from selectable markers or other external gene insertions, permitting more precise study of cell cycle-related diseases without confounding influences of foreign DNA. Keywords: TALEN, CRISPR/Cas9, cyclin-dependent kinase inhibitor Received 20 October 2018; Revised version received 7 December 2018; Accepted 8 December 2018 The cell cycle constitutes a series of events required proteins can cause severe disease [16,25,33].
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Mut , Mut , Cbla, Cblb
    0031-3998/07/6202-0225 PEDIATRIC RESEARCH Vol. 62, No. 2, 2007 Copyright © 2007 International Pediatric Research Foundation, Inc. Printed in U.S.A. Long-Term Outcome in Methylmalonic Acidurias Is Influenced (by the Underlying Defect (mut0, mut؊, cblA, cblB FRIEDERIKE HO¨ RSTER, MATTHIAS R. BAUMGARTNER, CAROLINE VIARDOT, TERTTU SUORMALA, PETER BURGARD, BRIAN FOWLER, GEORG F. HOFFMANN, SVEN F. GARBADE, STEFAN KO¨ LKER, AND E. REGULA BAUMGARTNER Department of General Pediatrics [F.H., P.B., G.F.H., S.F.G., S.K.], Division of Inborn Metabolic Diseases, University Children’s Hospital, D-69120 Heidelberg, Germany; Metabolic Unit [C.V., T.S., B.F. E.R.B.], University Children’s Hospital Basel, CH-4005 Basel, Switzerland; Division of Metabolism and Molecular Pediatrics [M.R.B.], University Children’s Hospital Zu¨rich, CH-8032 Zu¨rich, Switzerland ABSTRACT: Isolated methylmalonic acidurias comprise a hetero- mut0 defect with complete loss of MCM activity (1). Both geneous group of inborn errors of metabolism caused by defects of defects are caused by mutations in the MUT gene and there- 0 – methylmalonyl-CoA mutase (MCM) (mut , mut ) or deficient syn- fore belong to the same complementation group (MIM thesis of its cofactor 5=-deoxyadenosylcobalamin (AdoCbl) (cblA, #251000). Using somatic complementation analysis, defects cblB). The aim of this study was to compare the long-term outcome of AdoCbl synthesis can be subdivided into several groups, in patients from these four enzymatic subgroups. Eighty-three pa- tients with isolated methylmalonic acidurias (age 7–33 y) born three of which cause isolated methylmalonic acidurias, i.e. between 1971 and 1997 were enzymatically characterized and pro- cblA, cblB, and, less frequently, cblD defects (2).
    [Show full text]
  • Generating Mouse Models for Biomedical Research: Technological Advances Channabasavaiah B
    © 2019. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2019) 12, dmm029462. doi:10.1242/dmm.029462 AT A GLANCE Generating mouse models for biomedical research: technological advances Channabasavaiah B. Gurumurthy1,2 and Kevin C. Kent Lloyd3,4,* ABSTRACT recombination in embryonic stem cells has given way to more refined Over the past decade, new methods and procedures have been methods that enable allele-specific manipulation in zygotes. We also developed to generate geneticallyengineered mouse models of human highlight advances in the use of programmable endonucleases that disease. This At a Glance article highlights several recent technical have greatly increased the feasibility and ease of editing the mouse advances in mouse genome manipulation that have transformed genome. Together, these and other technologies provide researchers our ability to manipulate and study gene expression in the mouse. with the molecular tools to functionally annotate the mouse genome We discuss how conventional gene targeting by homologous with greater fidelity and specificity, as well as to generate new mouse models using faster, simpler and less costly techniques. 1Developmental Neuroscience, Munroe Meyer Institute for Genetics and KEY WORDS: CRISPR, Genome editing, Mouse, Mutagenesis Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. 2Mouse Genome Engineering Core Facility, Vice Chancellor for Research Office, University of Nebraska Medical Center, Omaha, NE 68106-5915, USA. Introduction 3Department
    [Show full text]